The Latest Breaking News from Nasdaq

Atlassian Corporation (NASDAQ:TEAM) has outperformed the market over the past 5 years by 40.44% on an annualized basis producing an average annual return of 54.18%. Currently, Atlassian Corporation has a market capitalization of $68.95 billion.

The second earnings season of the year is due to start next week once the US banks report how they performed in the first three months of 2022. Earnings Surprises Dominated The Last Earnings Season

Teradyne Inc's (NASDAQ:TER) short percent of float has fallen 5.04% since its last report. The company recently reported that it has 5.49 million shares sold short, which is 3.39% of all regular shares that are available for trading.

Streaming giant Netflix Inc (NASDAQ: NFLX) is well-known for its partnered content and original programming. Could live sports and a continued focus on sports docuseries be a huge growth driver for the company going forward?

Piper Sandler analyst Kashy Harrison downgraded two electrical equipment companies, citing the U.S. Department of Commerce's decision to investigate antidumping and countervailing duty circumvention in certain Southeast Asian countries that will cause project delays.

The year got off to a bumpy start for investors, and the S&P 500 is now down 5.6% year-to-date in 2022.

C4 Therapeutics Inc (NASDAQ: CCCC) shares are trading significantly lower Friday afternoon after the company presented data from Cohort A of its ongoing Phase 1/2 clinical trial of CFT7455.

Needham is initiating coverage on STAAR Surgical Company (NASDAQ:STAA) with a Buy rating and an $87 price target. The analysts note that FDA approval of STAA's EVO Implantable Collamer Lens (ICLs) should serve as a meaningful tailwind for revenue. The Company generates most of its revenue from outside US markets. But after the FDA approval…

Clovis Oncology Inc (NASDAQ: CLVS) announced two abstracts featuring 

Christian Angermayer, founder and chairman of Atai Life Sciences (NASDAQ:ATAI), told Twitter that he bought 1 million shares of his company. “Many #biotech stocks are cheap at the moment. In my opinion, Atai Life Sciences AG stands out though for two reasons: the size of the market (unfortunately) the fact…

Dollar Tree (NASDAQ:DLTR) has outperformed the market over the past 5 years by 2.38% on an annualized basis producing an average annual return of 16.21%. Currently, Dollar Tree has a market capitalization of $36.78 billion.